Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
Main Authors: | Sandro C. Esteves, Claus Yding Andersen, Robert Fischer, Peter Humaidan, Carlo Alviggi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.719647/full |
Similar Items
-
Management Strategies for POSEIDON Groups 3 and 4
by: Thor Haahr, et al.
Published: (2019-09-01) -
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
by: Sandro C. Esteves, et al.
Published: (2019-11-01) -
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
by: Sandro C. Esteves, et al.
Published: (2018-08-01) -
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
by: Sandro C. Esteves, et al.
Published: (2021-03-01) -
Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
by: Peter Humaidan, et al.
Published: (2019-07-01)